Susan H. Eshleman
Affiliations: | Cellular and Molecular Medicine | Johns Hopkins University School of Medicine, Baltimore, MD, United States |
Area:
HIVWebsite:
http://cmm.jhu.edu/index.php?title=Susan_H._EshlemanGoogle:
"Susan H. Eshleman"Mean distance: 21373.2 (cluster 6)
Cross-listing: ID Tree
Children
Sign in to add trainee| Tamara S. Flys | grad student | 2008 | Johns Hopkins |
| Jessica D. Church | grad student | 2009 | Johns Hopkins |
| Iris Chen | grad student | 2011 | Johns Hopkins |
| Jessica M. Fogel | grad student | 2012 | Johns Hopkins |
| Maria M. James | grad student | 2012 | Johns Hopkins |
| Kin Israel Notarte | grad student | 2022-2027 | Johns Hopkins Medical School (Physiology Academic Tree) |
BETA: Related publications
See more...
Publications
|
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
| Fogel JM, Persaud D, Piwowar-Manning E, et al. (2024) HIV DNA Levels in Persons Who Acquired HIV in the Setting of Long-Acting Cabotegravir for HIV Prevention: Analysis of Cases from HPTN 083 and 084. Aids Research and Human Retroviruses |
| Grant-McAuley W, Morgenlander WR, Ruczinski I, et al. (2024) Identification of antibody targets associated with lower HIV viral load and viremic control. Plos One. 19: e0305976 |
| Landovitz RJ, Delany-Moretlwe S, Fogel JM, et al. (2024) Features of HIV Infection in the Context of Long-Acting Cabotegravir Preexposure Prophylaxis. The New England Journal of Medicine |
| Fogel JM, Piwowar-Manning E, Moser A, et al. (2024) Evaluation of Xpert point-of-care assays for detection of HIV infection in persons using long-acting cabotegravir for pre-exposure prophylaxis. Microbiology Spectrum. e0030724 |
| Moore HP, Palumbo PJ, Notarte KI, et al. (2024) Performance of the Applied Biosystems HIV-1 Genotyping Kit with Integrase. Journal of Clinical Microbiology. e0013624 |
| Hall M, Golubchik T, Bonsall D, et al. (2023) Demographics of sources of HIV-1 transmission in Zambia: a molecular epidemiology analysis in the HPTN 071 PopART study. The Lancet. Microbe |
| Landovitz RJ, Hanscom BS, Clement ME, et al. (2023) Efficacy and safety of long-acting cabotegravir compared with daily oral tenofovir disoproxil fumarate plus emtricitabine to prevent HIV infection in cisgender men and transgender women who have sex with men 1 year after study unblinding: a secondary analysis of the phase 2b and 3 HPTN 083 randomised controlled trial. The Lancet. Hiv |
| Grant-McAuley W, Piwowar-Manning E, Clarke W, et al. (2023) Population-level analysis of natural control of HIV infection in Zambia and South Africa: HPTN 071 (PopART). Journal of the International Aids Society. 26: e26179 |
| Marzinke MA, Hanscom B, Wang Z, et al. (2023) Efficacy, safety, tolerability, and pharmacokinetics of long-acting injectable cabotegravir for HIV pre-exposure prophylaxis in transgender women: a secondary analysis of the HPTN 083 trial. The Lancet. Hiv |
| Grant-McAuley W, Morgenlander W, Hudelson SE, et al. (2023) Comprehensive profiling of pre-infection antibodies identifies HIV targets associated with viremic control and viral load. Frontiers in Immunology. 14: 1178520 |